Future Cell Japan Co., Ltd. Started industry-academia joint research with the University of Tokyo

 Future Cell Japan Co., Ltd. has started joint research with the Center for Disease and Biomedical Engineering, Graduate School of Medicine, University of Tokyo.

Future Cell Japan Co., Ltd. has been developing cosmetics and selling raw materials using human umbilical cord blood cell culture supernatant, etc., but this time, for the purpose of developing new cosmetic raw materials and evaluating their functionality, Reiwa From December 3rd, we signed a joint research contract with the University of Tokyo. With the start of joint research, a researcher was dispatched from Future Cell Japan Co., Ltd. to start development.

Based on the research of Associate Professor Seiichiro Osako, who is active in the front line of research on the arylhydrocarbon receptor (AhR) that contributes to the remission of allergic atopic dermatitis and psoriasis, which is an autoimmune disease. We aim to develop new cosmetic raw materials by exposing growth factor and iPS cell culture supernatant to the skin in a complex manner and analyzing their functions at the level of histopathology and gene expression.

Comments

Popular posts from this blog

L'Oréal forms research and technology alliance with Israeli climate tech company

"THE SONOKO White Mask" for moisturizing and transparent skin of adults

L'Oreal Research & Innovation, Morishita Jintan Co., Ltd. and L'Oreal's first successful development of cutting-edge "active delivery capsules" made of useful ingredients for plant-derived cosmetics